Cargando…
Parasite Load Decrease during Application of a Safe and Easily Applied Antileishmanial Aminoglycoside Cream
Autores principales: | Salah, Afif Ben, Zaâtour, Amor, Ben Messaoud, Nathalie, Kidar, Abdelhamid, Smith, Philip L., Kopydlowski, Karen M., Kreishman-Deitrick, Mara, Nielsen, Carl J., Novitt-Moreno, Anne, Ransom, Janet H., Morizot, Gloria, Grogl, Max, Buffet, Pierre A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031053/ https://www.ncbi.nlm.nih.gov/pubmed/24853096 http://dx.doi.org/10.1371/journal.pntd.0002749 |
Ejemplares similares
-
WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study
por: Ben Salah, Afif, et al.
Publicado: (2009) -
Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers
por: Mouri, Oussama, et al.
Publicado: (2023) -
In Response
por: Grogl, Max, et al.
Publicado: (2014) -
Randomized, Double-Blinded, Phase 2 Trial of WR 279,396 (Paromomycin and Gentamicin) for Cutaneous Leishmaniasis in Panama
por: Sosa, Néstor, et al.
Publicado: (2013) -
RAPD-PCR reveals genetic polymorphism among Leishmania major strains from Tunisian patients
por: Yazidi, Rihab, et al.
Publicado: (2015)